NO902823L - Preparat inneholdende protein s samt fremstilling derav. - Google Patents

Preparat inneholdende protein s samt fremstilling derav.

Info

Publication number
NO902823L
NO902823L NO90902823A NO902823A NO902823L NO 902823 L NO902823 L NO 902823L NO 90902823 A NO90902823 A NO 90902823A NO 902823 A NO902823 A NO 902823A NO 902823 L NO902823 L NO 902823L
Authority
NO
Norway
Prior art keywords
preparation
containing protein
protein
content
thromboses
Prior art date
Application number
NO90902823A
Other languages
English (en)
Other versions
NO902823D0 (no
Inventor
Hans Peter Schwarz
Ewald Molinari
Yendra Linnau
Susanne Pfeiler
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO902823D0 publication Critical patent/NO902823D0/no
Publication of NO902823L publication Critical patent/NO902823L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Preparat til behandling hhv. forhindring av tromboser hhv. tromboemboliske komplikasjoner, som inneholder protein S i en konsentrasjon som er minst 50 ganger konsentrasjonen i nativt plasma, og som er fritt for C4- binding-protein, eventuelt i kombinasjon med aktivert protein C.
NO90902823A 1989-06-26 1990-06-25 Preparat inneholdende protein s samt fremstilling derav. NO902823L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0155189A AT402153B (de) 1989-06-26 1989-06-26 Protein-s-hältige pharmazeutische präparation

Publications (2)

Publication Number Publication Date
NO902823D0 NO902823D0 (no) 1990-06-25
NO902823L true NO902823L (no) 1990-12-27

Family

ID=3515833

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902823A NO902823L (no) 1989-06-26 1990-06-25 Preparat inneholdende protein s samt fremstilling derav.

Country Status (10)

Country Link
US (1) US5143901A (no)
EP (1) EP0406216B1 (no)
JP (1) JPH0338528A (no)
AT (2) AT402153B (no)
CA (1) CA2019745C (no)
DE (1) DE59003060D1 (no)
DK (1) DK0406216T3 (no)
ES (1) ES2061007T3 (no)
FI (1) FI94927C (no)
NO (1) NO902823L (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
DK0658168T3 (da) * 1992-08-27 2001-01-22 Sanquin Bloedvoorziening Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
US7074402B2 (en) * 2000-02-04 2006-07-11 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)
EP4153636A1 (en) * 2020-06-29 2023-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-protein s single-domain antibodies and polypeptides comprising thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
WO1989002747A1 (en) * 1987-10-05 1989-04-06 The American National Red Cross Therapeutic thrombolytic composition

Also Published As

Publication number Publication date
ATE95818T1 (de) 1993-10-15
JPH0338528A (ja) 1991-02-19
FI903197A0 (fi) 1990-06-26
AT402153B (de) 1997-02-25
DE59003060D1 (de) 1993-11-18
ATA155189A (de) 1996-07-15
DK0406216T3 (da) 1994-01-17
FI94927B (fi) 1995-08-15
US5143901A (en) 1992-09-01
CA2019745A1 (en) 1990-12-26
NO902823D0 (no) 1990-06-25
CA2019745C (en) 1996-12-31
FI94927C (fi) 1995-11-27
ES2061007T3 (es) 1994-12-01
EP0406216A3 (en) 1991-02-06
EP0406216A2 (de) 1991-01-02
EP0406216B1 (de) 1993-10-13

Similar Documents

Publication Publication Date Title
ZA908953B (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
DE68924623D1 (de) Polytetrafluorethylenfilament und Verfahren zur Herstellung derselben.
GR880300077T1 (en) Galanthamine or analogues thereof for treating alzheimer's disease
BR9809171A (pt) Processo de tratamento de uma matéria-prima láctica, contendo gmp
SE8802781L (sv) Foerfarande foer avfuktning av gaser
ES2051768T3 (es) Compuestos farmaceuticos mejorados con contenido de metales.
DE69003977D1 (de) Verfahren und Einrichtung zur Bestimmung des Stengelgehaltes von Tabak.
NO910945D0 (no) Synergistisk soetemiddelblanding, dens anvendelse i tyggegummi, samt fremgangsmaate for fremstilling av blandingen.
KR890011606A (ko) 항응고제
NO902823D0 (no) Preparat inneholdende protein s samt fremstilling derav.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
NO920331D0 (no) Biologisk preparat samt bruk derav
DE68921908D1 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
DE69327812D1 (de) Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
DE68923486D1 (de) Behandlung gefährlicher Stoffe mit wässerigem Luftschaum von Polyhydroxypolymer.
DE3852227D1 (de) Immunologisches Nachweisverfahren für Herbizide.
ATE52894T1 (de) Schwarztrueffelaroma.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
DE68900776D1 (de) Verfahren und vorrichtung zur reduzierung des feuchtigkeitsgehaltes von nassen faeden.
DE69111457D1 (de) Katheter und vorrichtung zur behandlung, insbesondere von lungenembolien.
DE68913779D1 (de) D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid.
IE900460L (en) Pharmaceutical composition
DE58908780D1 (de) Verfahren zur Feststellung des Alkoholgehaltes und/oder des Heizwertes von Kraftstoffen.
IE830836L (en) Spiro-chroman-imidazolines